Transgenomic Inc. (Nasdaq: TBIO) launched its new Multiplexed ICE COLD-PCR (MS-ICP) CLIA to detect mutations in cancer patients. Shares of the biotechnology firm leaped $1.07 to $2.96.
Transgenomic launches mutation detector
May 29, 2015 at 12:20 PM EDT
